Platelet-activating factor directly stimulates endothelial cell migration and promotes in vivo angiogenesis through a receptor-dependent mechanism that requires heparin at physiologic concentrations.
No takes yet. Share an insight, caveat, or question.
Does not inform clinical angiogenesis management; leaves open PAF as a therapeutic target pending human studies.
Camussi et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: